Ariad - Xconomy

by in

Entry	Author	Date	Location
FDA Approves Ariad Leukemia Drug Three Months Ahead of Schedule	Catherine Arnst	12/14/12	Boston
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs	Arlene Weintraub	05/31/12	New York
Ariad and Merck Face Tough FDA Review of Sarcoma Pill	Arlene Weintraub	03/20/12	Boston
Ariad Brings Third Cancer Drug Into Human Trials	Arlene Weintraub	09/22/11	Boston
Ariad and Merck Say Sarcoma Drug Improves Survival	Arlene Weintraub	06/06/11	Boston
Ariad Persuades Court to Allow Immediate Appeal of Ruling in Favor of Amgen	Luke Timmerman	10/06/08	Boston
Page 1 of 1

Xconomy National